Compare, Analyse Sun Pharma with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUN PHARMA vs ADCOCK INGRAM (S. Africa) - Comparison Results

SUN PHARMA     Change

Sun Pharma holds 3.7% share of the domestic pharma market (as per the latest ORG IMS MAT data) and has a strong presence in the lifestyle therapeutic segments. The company started focusing on the exports market in FY02, when it increased its stake to... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 SUN PHARMA   ADCOCK INGRAM
EQUITY SHARE DATA
    SUN PHARMA
Mar-20
ADCOCK INGRAM
Jun-14
SUN PHARMA/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs484376-   
Low Rs315271-   
Sales per share (Unadj.) Rs136.9111.7-  
Earnings per share (Unadj.) Rs17.5-28.1-  
Cash flow per share (Unadj.) Rs26.0-23.3-  
Dividends per share (Unadj.) Rs4.000-  
Dividend yield (eoy) %1.00-  
Book value per share (Unadj.) Rs188.787.7-  
Shares outstanding (eoy) m2,399.26168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.92.9 100.9%   
Avg P/E ratio x22.9-11.5 -199.5%  
P/CF ratio (eoy) x15.4-13.9 -110.9%  
Price / Book Value ratio x2.13.7 57.5%  
Dividend payout %22.90-   
Avg Mkt Cap Rs m958,86454,555 1,757.6%   
No. of employees `00017.84.3 413.7%   
Total wages/salary Rs m63,6243,424 1,858.2%   
Avg. sales/employee Rs Th18,490.64,392.1 421.0%   
Avg. wages/employee Rs Th3,582.6797.6 449.2%   
Avg. net profit/employee Rs Th2,357.6-1,106.7 -213.0%   
INCOME DATA
Net Sales Rs m328,37518,855 1,741.6%  
Other income Rs m6,360132 4,816.6%   
Total revenues Rs m334,73518,987 1,762.9%   
Gross profit Rs m69,898-3,267 -2,139.2%  
Depreciation Rs m20,528814 2,522.5%   
Interest Rs m3,027511 592.7%   
Profit before tax Rs m52,702-4,460 -1,181.7%   
Minority Interest Rs m0-12 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-2,6060-   
Tax Rs m8,228279 2,952.4%   
Profit after tax Rs m41,868-4,751 -881.2%  
Gross profit margin %21.3-17.3 -122.8%  
Effective tax rate %15.6-6.2 -249.9%   
Net profit margin %12.8-25.2 -50.6%  
BALANCE SHEET DATA
Current assets Rs m316,54213,810 2,292.1%   
Current liabilities Rs m157,0647,770 2,021.4%   
Net working cap to sales %48.632.0 151.6%  
Current ratio x2.01.8 113.4%  
Inventory Days Days88111 78.9%  
Debtors Days Days105124 84.5%  
Net fixed assets Rs m243,1028,050 3,020.0%   
Share capital Rs m2,39988 2,740.7%   
"Free" reserves Rs m450,2450-   
Net worth Rs m452,64514,799 3,058.6%   
Long term debt Rs m20,2895,201 390.1%   
Total assets Rs m682,52527,957 2,441.3%  
Interest coverage x18.4-7.7 -238.1%   
Debt to equity ratio x00.4 12.8%  
Sales to assets ratio x0.50.7 71.3%   
Return on assets %6.6-15.2 -43.4%  
Return on equity %9.2-32.1 -28.8%  
Return on capital %11.2-19.8 -56.7%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m46,2550-   
CASH FLOW
From Operations Rs m65,5481,609 4,072.7%  
From Investments Rs m-25,888-494 5,238.7%  
From Financial Activity Rs m-57,1514,720 -1,210.8%  
Net Cashflow Rs m-13,8575,835 -237.5%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 5.18 Rs / ZAR

Compare SUN PHARMA With: MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare SUN PHARMA With: FRESENIUS KABI ONCO.  DR. DATSONS LABS  TORRENT PHARMA  AUROBINDO PHARMA  FULFORD INDIA  



Today's Market

Sensex Ends 257 Points Higher; Tata Steel & Hindalco Among Top Nifty Gainers(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended higher.

Related Views On News

SUN PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 87.4% (Quarterly Result Update)

Feb 1, 2021 | Updated on Feb 1, 2021

For the quarter ended December 2020, SUN PHARMA has posted a net profit of Rs 19 bn (up 87.4% YoY). Sales on the other hand came in at Rs 88 bn (up 8.4% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA 2019-20 Annual Report Analysis (Annual Result Update)

Dec 11, 2020 | Updated on Dec 11, 2020

Here's an analysis of the annual report of SUN PHARMA for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

SUN PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 66.9% (Quarterly Result Update)

Nov 6, 2020 | Updated on Nov 6, 2020

For the quarter ended September 2020, SUN PHARMA has posted a net profit of Rs 19 bn (up 66.9% YoY). Sales on the other hand came in at Rs 86 bn (up 5.3% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

Why Did Alembic Pharma Shares Fall Today? (Views On News)

May 5, 2021

Covid-led supply disruptions of API fuel Alembic Pharma's global prospects.

SUN PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Aug 6, 2019 | Updated on Aug 6, 2019

Here's an analysis of the annual report of SUN PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

More Views on News

Most Popular

Time to Buy Smallcaps? (Fast Profits Daily)

Apr 30, 2021

In this video, I'll show you why I favour smallcaps over the Nifty.

The Next Smallcap Winners (Profit Hunter)

Apr 30, 2021

Price is the only due diligence one might require to buy this business.

Sell in May and Go Away? (Fast Profits Daily)

Apr 28, 2021

Does the concept of selling stocks in the month of May, work in the Indian market?

This Fund Manager Has Taken the World by Storm. Will You Invest With Her? (Profit Hunter)

Apr 26, 2021

Should you invest with this Rockstar fund manager who has outperformed in a big way?

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

FREE Event: Discover Your First Stock for a Potential Rs 7 Crore in Long-term Wealth
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

SUN PHARMA SHARE PRICE


May 7, 2021 (Close)

TRACK SUN PHARMA

  • Track your investment in SUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUN PHARMA

SUN PHARMA 5-YR ANALYSIS

COMPARE SUN PHARMA WITH

FEATURED VIDEOS

The 'Big' Money is in this 'Small' Detail

Stability, Quality or Green Stocks for 2021?

Market Crash: Picture Abhi Baaki Hai?

It's a Great Time to Buy Gold

More Featured Videos

MARKET STATS